Entinostat/pembrolizumabLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30736-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：595 / 595

相关论文

共 50 条

[41] PembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2025, 2056 (1) :465-465

[42] Catequentinib/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1933 (1) :138-138

[43] Catequentinib/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2021, 1869 (1) :93-93

[44] Axitinib/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2024, 2030 (1) :81-81

[45] Dacarbazine/pembrolizumabLack of efficacy : case report [J].

Reactions Weekly, 2024, 2020 (1) :170-170

[46] Nivolumab/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1935 (1) :347-347

[47] Nivolumab/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2025, 2040 (1) :759-759

[48] Dexamethasone/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2023, 1970 (1) :116-116

[49] PembrolizumabLack of efficacy and hypothyroidism: case report [J].

Reactions Weekly, 2023, 1950 (1) :330-330

[50] Antineoplastics/pembrolizumabLack of efficacy: case report [J].

Reactions Weekly, 2022, 1919 (1) :91-91

← 1 2 3 4 5 →